Advertisement

Switzerland approves Moderna vaccine for teenagers

AFP
AFP - [email protected]
Switzerland approves Moderna vaccine for teenagers
This picture taken in Monts, central France, on April 22, 2021, shows a vial of the Moderna Covid-19 disease vaccine at Recipharm plant. - Recipharm has been chosen by the American biotech Moderna to produce part of its candidate vaccine against Covid-19 in France. (Photo by GUILLAUME SOUVANT / AFP)

Switzerland has now approved both of its vaccines for use among people as young as 12.

Advertisement

Switzerland on Monday approved Moderna's Covid-19 vaccine for youngsters aged between 12 and 17 years old, weeks after EU regulators authorised the drug for the same age group.

The Swissmedic regulatory authority, which has already approved the Pfizer-BioNTech jab for over-12s, said results from an ongoing study showed Moderna had 93 percent efficacy in the young age group.

"The vaccine produced a similar immune response... in this study compared to young adults aged 18 to 25 years," the regulator said.

Advertisement

Switzerland, which is not in the European Union, has its own regulatory process and was the first country in continental Europe to start using the Pfizer-BioNTech jab.

READ MORE: Switzerland to start Covid vaccinations for teenagers

The country has doled out more than 9.1 million doses and nearly 49.2 percent of the population of 8.6 million are now fully vaccinated. However, take-up has slowed in recent weeks. Nearly 2.5 million doses were administered in June but fewer than 1.4 million in July.

The virus has killed 10,354 people in Switzerland and 723,907 positive tests have been registered.

Moderna's Covid-19 jab is used in 48 countries, behind AstraZeneca (161), Pfizer-BioNTech (88) and Sinopharm (49), according to an AFP count.

More

Comments

Join the conversation in our comments section below. Share your own views and experience and if you have a question or suggestion for our journalists then email us at [email protected].
Please keep comments civil, constructive and on topic – and make sure to read our terms of use before getting involved.

Please log in to leave a comment.

See Also